Cargando…
Dose-dependent effect of propranolol on the hemodynamic response in cirrhotic patients with gastroesophageal varices
OBJECTIVE: Propranolol is always titrated to the maximum tolerated dose to prevent gastroesophageal variceal bleeding. However, some patients do not achieve a hemodynamic response and experience more intolerance and discontinuation. This study evaluated the dose-dependent effect of propranolol on he...
Autores principales: | Zhang, Feng, Xu, Hui, Chen, Min, Zhang, Ming, Xiao, Jiangqiang, Wang, Yi, He, Qibin, Zhang, Wei, Yin, Xiaochun, Zou, Xiaoping, Zhuge, Yuzheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380447/ https://www.ncbi.nlm.nih.gov/pubmed/30422868 http://dx.doi.org/10.1097/MEG.0000000000001293 |
Ejemplares similares
-
Number of endoscopic sessions to eradicate varices identifies high risk of rebleeding in cirrhotic patients
por: Guo, Huiwen, et al.
Publicado: (2022) -
Increase in Free Hepatic Venous Pressure Response to Beta-Blockers Predicts Variceal Bleeding in Cirrhotic Patients
por: Guo, Huiwen, et al.
Publicado: (2021) -
A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients
por: Yin, Xiaochun, et al.
Publicado: (2020) -
Spleen Stiffness Predicts Survival after Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients
por: Zhu, Hao, et al.
Publicado: (2020) -
Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial
por: Qi, Xingshun, et al.
Publicado: (2013)